Back to Search Start Over

T.04.5: COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR.

Authors :
Mordà, F.
Hancox, S.
Black, C.J.
Selinger, C.
Source :
Digestive & Liver Disease; 2024 Supplement 2, Vol. 56, pS239-S239, 1p
Publication Year :
2024

Details

Language :
English
ISSN :
15908658
Volume :
56
Database :
Supplemental Index
Journal :
Digestive & Liver Disease
Publication Type :
Academic Journal
Accession number :
176502733
Full Text :
https://doi.org/10.1016/S1590-8658(24)00592-9